Anaxsys Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Anaxsys General Information
Description
Developer of respiratory devices designed to monitor and screen asthma, lung cancer, and other respiratory diseases. The company's devices monitor respiratory rates in post-operative, trauma, and emergency procedure patients by way of early detection of respiratory illnesses, enabling healthcare professionals to enhance patient safety.
Contact Information
Website
www.anaxsys.comCorporate Office
- Unit 6, Send Business Centre
- 3 Tannery House, Tannery Lane, Surrey
- Send GU23 7EF
- England, United Kingdom
Corporate Office
- Unit 6, Send Business Centre
- 3 Tannery House, Tannery Lane, Surrey
- Send GU23 7EF
- England, United Kingdom
Anaxsys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 26-Aug-2024 | Completed | Out of Business | |||
| 12. Secondary Transaction - Private | 01-Feb-2023 | Completed | Clinical Trials - General | |||
| 11. Later Stage VC | 08-Apr-2016 | Completed | Clinical Trials - General | |||
| 10. Grant | 17-Sep-2015 | Completed | Clinical Trials - General | |||
| 9. Secondary Transaction - Private | 02-Apr-2015 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC | 17-Dec-2013 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC | 12-Jun-2012 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC | 30-Nov-2010 | Completed | Clinical Trials - General | |||
| 5. Grant | 01-May-2010 | $1.07M | $6.42M | Completed | Clinical Trials - General | |
| 4. Later Stage VC | 01-Jan-2010 | $2.8M | $6.42M | Completed | Clinical Trials - General |
Anaxsys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary 2 | ||||||||
| Ordinary 1 | ||||||||
| Ordinary | 111,376 | $0.142657 | $5.71 | $5.71 | 1x | $5.71 | 11.8% |
Anaxsys Patents
Anaxsys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120165693-A1 | Detection of respiratory system lesions | Active | 02-Sep-2010 | ||
| US-8403861-B2 | Detection of respiratory system lesions | Inactive | 02-Sep-2010 | ||
| GB-2474831-A | Adjusting the impedance of an electrochemical sensor | Inactive | 01-Sep-2009 | ||
| GB-0915162-D0 | Electrochemical sensor | Inactive | 01-Sep-2009 | ||
| GB-0904109-D0 | Method and apparatus for determining lung function of a subject | Inactive | 10-Mar-2009 |
Anaxsys Signals
Anaxsys FAQs
-
When was Anaxsys founded?
Anaxsys was founded in 2002.
-
Where is Anaxsys headquartered?
Anaxsys is headquartered in Send, United Kingdom.
-
What is the size of Anaxsys?
Anaxsys has 4 total employees.
-
What industry is Anaxsys in?
Anaxsys’s primary industry is Monitoring Equipment.
-
Is Anaxsys a private or public company?
Anaxsys is a Private company.
-
What is Anaxsys’s current revenue?
The current revenue for Anaxsys is .
-
How much funding has Anaxsys raised over time?
Anaxsys has raised $11.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process